The theme for Bactiguard in 2022 were its investments in product development, regulatory issues, production capacity and commercial ability relating both to BIP sales and to licensing. This platform for future growth will, we believe, again be emphasised in the Q4/22 results and, with investment being sustained in 2023, it should materialise into stronger operating leverage in the medium to long term.
LÄS MER